LCN2 and Alzheimer disease: Moreover, the overexpression of CX3CL1 and LCN2 explicates a protective role, modulating the severity of the neuroinflammation process: the expression of CX3CL1 is significantly decreased in AD and inversely correlated to AD severity [85].